4.7 Article

The NF-κB regulator Bcl-3 restricts terminal differentiation and promotes memory cell formation of CD8+ T cells during viral infection

Journal

PLOS PATHOGENS
Volume 17, Issue 1, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.ppat.1009249

Keywords

-

Funding

  1. Intramural Research Program of National Institute of Allergy and Infectious Diseases (NIAID), NIH
  2. National Cancer Institute, Center for Cancer Research, NIH
  3. CCR Single Cell Analysis Facility
  4. FNLCR [HHSN261200800001E]

Ask authors/readers for more resources

Bcl-3 plays a crucial cell-autonomous role in regulating the balance between memory and terminal effector cells during CD8(+) T cell differentiation. Underexpression of Bcl-3 leads to skewed differentiation towards terminal effector cells and decreased memory cell formation, while overexpression enhances memory precursor cell formation.
Bcl-3 is an atypical member of the I kappa B family that acts in the nucleus to modulate transcription of many NF-kappa B targets in a highly context-dependent manner. Accordingly, complete Bcl-3(-/-) mice have diverse defects in both innate and adaptive immune responses; however, direct effects of Bcl-3 action in individual immune cell types have not been clearly defined. Here, we document a cell-autonomous role for Bcl-3 in CD8(+) T cell differentiation during the response to lymphocytic choriomeningitis virus infection. Single-cell RNA-seq and flow cytometric analysis of virus-specific Bcl3(-/-) CD8(+) T cells revealed that differentiation was skewed towards terminal effector cells at the expense of memory precursor effector cells (MPECs). Accordingly, Bcl3(-/-) CD8(+) T cells exhibited reduced memory cell formation and a defective recall response. Conversely, Bcl-3-overexpression in transgenic CD8(+) T cells enhanced MPEC formation but reduced effector cell differentiation. Together, our results establish Bcl-3 as an autonomous determinant of memory/terminal effector cell balance during CD8(+) T cell differentiation in response to acute viral infection. Our results provide proof-of-principle for targeting Bcl-3 pharmacologically to optimize adaptive immune responses to infectious agents, cancer cells, vaccines and other stimuli that induce CD8(+) T cell differentiation. Author summary Effective immunity to previously encountered pathogens or vaccines depends on efficient formation of memory T and B cells. A major cornerstone is the generation of memory CD8(+) T cells, which kill cells infected with intracellular pathogens, including viruses. In addition, memory CD8(+) T cells are critical for adoptive immunotherapy to eliminate targeted tumor cells. Hence, it is essential to have a detailed understanding of pathways and molecular factors that regulate T cell differentiation/memory formation during the initial immune effector response. Here we show a critical cell-autonomous role for Bcl-3, an atypical member of the I kappa B family, in the regulation of CD8(+) T cell differentiation/memory formation during acute viral infection with lymphocytic choriomeningitis virus. We found that Bcl-3 dampens the terminal differentiation of CD8(+) T cells, which normally results in death at the end of the primary effector response, and instead, promotes the formation of memory precursor cells early on. This led to a robust memory response and much improved viral clearance upon re-challenge. Our results provide new insight into the molecular regulation of CD8(+) T cell effector response and memory cell generation, establishing Bcl-3 and its pathways as a target to optimize CD8(+) T cell effector responses to various immunogens including infectious agents, cancer cells, and vaccines.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available